Skip to main content
Clarification of local SARS prevention methods Temporary guidelines for the prevention, diagnosis and treatment of new coronavirus infection (COVID-19), published by the Ministry of Health of Russia, contain information on the possibility of using an isotonic solution of sodium chloride as a method for preventing infection with coronavirus infection. In connection with the appeals of the media, the Ministry of Health of Russia clarifies. When acute respiratory viral infections (ARVI) occur, as a rule, the mucous membrane of the nose and throat is affected. This is manifested in the form of nasal congestion, perturbation and sore throat and is called rhinitis and pharyngitis, respectively. Coronavirus infection refers to ARVI, so approaches to prevention and symptomatic treatment are similar. A standard approach to the prevention and local treatment of rhinitis and pharyngitis is the use of an isotonic solution of sodium chloride (sometimes called "saline," often it is ma
Posts
Puerto Rico Reopening Beaches on Saturday Amid Drop in Coronavirus Cases Puerto Rico is reopening beaches, casinos, gyms and movie theaters Saturday for three weeks, following a drop in new coronavirus cases. Gov. Wanda Vázquez said the changes on the U.S. territory will be in effect until October 2. People are still required to wear masks and maintain a safe social distance, especially at the beach. The 10 p.m.-5 a.m. curfew for bars and nightclubs will remain in effect. Vázquez said she will lift a 24-hour lockdown on Sundays and allow restaurants to increase their capacity from 25% to 50%. Many business owners are praising the reopening, while some health experts warn if cases spike after the reopening, tighter restrictions will go into effect. So far, Puerto Rico has reported more than 36,000 coronavirus infections and more than 500 deaths. By VOA News . Read more Some US Hospitals Passing on Purchases of COVID Drug Some US Hospitals Passing on Purchases of COVID
Some US Hospitals Passing on Purchases of COVID Drug Some hospitals in the U.S. have been turning down part of their allocated supply of remdesivir, the COVID-19-fighting drug made by Gilead Sciences, the U.S. Health and Human Services Department confirmed Friday. From July 6 to September 8, state and territorial public health systems accepted about 72% of the remdesivir they were offered by HHS, a spokesperson confirmed Friday to Reuters. Hospitals then bought about two-thirds of what the states and territories accepted. The government has been leading the distribution of the drug, but that effort expires at the end of the month, and some hospitals are stockpiling remdesivir because they don’t know what the availability of the drug will be after September and want to be prepared if the pandemic flares this winter. Gilead did not respond to a request for comment from Reuters. Hospital say their supplies of the drug are adequate partly because they are only using it to treat the